Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.59 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.59 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.59 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 6/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.59 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.59 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.59 |
| ▸ | CDK2 | P24941 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29363189 | 0.90 | ALDH1A1 (0.62) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 | |
| SCHEMBL70219 | 0.90 | ALDH1A1 (0.62) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 | |
| SCHEMBL9115296 | 0.88 | ALDH1A1 (0.59) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 | |
| SCHEMBL7915327 | 0.87 | CDK2 (0.67) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 | |
| SCHEMBL12807356 | 0.85 | TRPA1 (0.50) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 | |
| SCHEMBL2467605 | 0.85 | CYP1A2 (0.62) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 | |
| Catechol SCHEMBL8935190 | 0.85 | ALDH1A1 (0.59) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 | |
| Pyrene SCHEMBL27795191 | 0.85 | ALDH1A1 (0.65) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 | |
| SCHEMBL6349397 | 0.84 | CDK2 (0.69) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 | |
| SCHEMBL31037125 | 0.84 | CDK2 (0.69) | ALDH1A1MEN1DNMT1CACNA1BAPBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113784708-A | Phenanthrene AMPK activator compounds, compositions, methods, and uses thereof | 雀巢产品有限公司 | 2021-12-10 | — | — | CN | claimed |
| CN-113784708-A | Phenanthrene AMPK activator compounds, compositions, methods, and uses thereof | 雀巢产品有限公司 | 2021-12-10 | — | — | CN | disclosed |
| CN-107652153-A | The four of ethene are poly- | 沙索技术有限公司 | 2018-02-02 | — | — | CN | disclosed |
| CN-105263890-B | Four poly- methods of ethene | 沙索技术有限公司 | 2017-12-05 | — | — | CN | disclosed |
| CN-104245640-B | Tetramerization of ethylene | 沙索技术有限公司 | 2017-10-27 | — | — | CN | disclosed |
| CN-105228973-B | Process for the oligomerization of ethylene to a mixture of 1-hexene and 1-octene | 沙索技术有限公司 | 2017-08-29 | — | — | CN | disclosed |
| US-9676907-B2 | Methods and systems of graft polymerization on a functionalized substrate | ASPEN RESEARCH CORPORATION (US) | 2017-06-13 | — | — | US | disclosed |
| US-20160168331-A1 | METHODS AND SYSTEMS OF GRAFT POLYMERIZATION ON A FUNCTIONALIZED SUBSTRATE | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2016-06-16 | — | — | US | disclosed |
| US-9267009-B2 | Methods and systems of graft polymerization on a functionalized substrate | ASPEN RESEARCH CORPORATION (US) | 2016-02-23 | — | — | US | disclosed |
| US-20140296366-A1 | METHODS AND SYSTEMS OF GRAFT POLYMERIZATION ON A FUNCTIONALIZED SUBSTRATE | ASPEN RESEARCH CORPORATION (US) | 2014-10-02 | — | — | US | disclosed |
| CN-103906775-A | Methods and systems of graft polymerization on functionalized substrate | ASPEN RES CORP | 2014-07-02 | — | — | CN | disclosed |
| US-20030092637-A1 | Novel compounds | XYLOGEN AB (SE) | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092637-A1 | Novel compounds | ENTPD5, G6PD, G6PC1 | ALDH1A1 986/4885MEN1 522/4885DNMT1 4214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.